- Home
- ADAP vs CIVB Comparison
ADAP vs CIVB Comparison
Compare ADAP & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CIVB
- Stock Information
- Founded
- ADAP 2008
- CIVB 1884
- Country
- ADAP United Kingdom
- CIVB United States
- Employees
- ADAP N/A
- CIVB N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CIVB Major Banks
- Sector
- ADAP Health Care
- CIVB Finance
- Exchange
- ADAP Nasdaq
- CIVB Nasdaq
- Market Cap
- ADAP 299.0M
- CIVB 274.6M
- IPO Year
- ADAP 2015
- CIVB N/A
- Fundamental
- Price
- ADAP $0.84
- CIVB $18.51
- Analyst Decision
- ADAP Strong Buy
- CIVB Hold
- Analyst Count
- ADAP 3
- CIVB 4
- Target Price
- ADAP $3.38
- CIVB $18.75
- AVG Volume (30 Days)
- ADAP 1.1M
- CIVB 47.7K
- Earning Date
- ADAP 11-06-2024
- CIVB 10-29-2024
- Dividend Yield
- ADAP N/A
- CIVB 3.46%
- EPS Growth
- ADAP N/A
- CIVB N/A
- EPS
- ADAP N/A
- CIVB 2.13
- Revenue
- ADAP $141,459,000.00
- CIVB $147,536,000.00
- Revenue This Year
- ADAP $172.21
- CIVB N/A
- Revenue Next Year
- ADAP N/A
- CIVB $4.45
- P/E Ratio
- ADAP N/A
- CIVB $8.69
- Revenue Growth
- ADAP 99.90
- CIVB N/A
- 52 Week Low
- ADAP $0.42
- CIVB $13.60
- 52 Week High
- ADAP $2.05
- CIVB $19.00
- Technical
- Relative Strength Index (RSI)
- ADAP 33.47
- CIVB 68.70
- Support Level
- ADAP $0.83
- CIVB $17.00
- Resistance Level
- ADAP $0.90
- CIVB $18.60
- Average True Range (ATR)
- ADAP 0.05
- CIVB 0.35
- MACD
- ADAP 0.00
- CIVB 0.06
- Stochastic Oscillator
- ADAP 6.76
- CIVB 94.37
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.